337 related articles for article (PubMed ID: 29746225)
1. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.
Hoffman LM; Veldhuijzen van Zanten SEM; Colditz N; Baugh J; Chaney B; Hoffmann M; Lane A; Fuller C; Miles L; Hawkins C; Bartels U; Bouffet E; Goldman S; Leary S; Foreman NK; Packer R; Warren KE; Broniscer A; Kieran MW; Minturn J; Comito M; Broxson E; Shih CS; Khatua S; Chintagumpala M; Carret AS; Escorza NY; Hassall T; Ziegler DS; Gottardo N; Dholaria H; Doughman R; Benesch M; Drissi R; Nazarian J; Jabado N; Boddaert N; Varlet P; Giraud G; Castel D; Puget S; Jones C; Hulleman E; Modena P; Giagnacovo M; Antonelli M; Pietsch T; Gielen GH; Jones DTW; Sturm D; Pfister SM; Gerber NU; Grotzer MA; Pfaff E; von Bueren AO; Hargrave D; Solanki GA; Jadrijevic Cvrlje F; Kaspers GJL; Vandertop WP; Grill J; Bailey S; Biassoni V; Massimino M; Calmon R; Sanchez E; Bison B; Warmuth-Metz M; Leach J; Jones B; van Vuurden DG; Kramm CM; Fouladi M
J Clin Oncol; 2018 Jul; 36(19):1963-1972. PubMed ID: 29746225
[TBL] [Abstract][Full Text] [Related]
2. The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma.
Yu X; Lai M; Li J; Wang L; Ye K; Zhang D; Hu Q; Li S; Hu X; Wang Q; Ma M; Xiao Z; Zhou J; Shi C; Luo L; Cai L
Neurosurg Rev; 2024 May; 47(1):212. PubMed ID: 38727935
[TBL] [Abstract][Full Text] [Related]
3. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).
Bailey S; Howman A; Wheatley K; Wherton D; Boota N; Pizer B; Fisher D; Kearns P; Picton S; Saran F; Gibson M; Glaser A; Connolly DJ; Hargrave D
Eur J Cancer; 2013 Dec; 49(18):3856-62. PubMed ID: 24011536
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
Mankuzhy NP; Tringale KR; Dunkel IJ; Farouk Sait S; Souweidane MM; Khakoo Y; Karajannis MA; Wolden S
Pediatr Blood Cancer; 2024 May; 71(5):e30929. PubMed ID: 38430472
[TBL] [Abstract][Full Text] [Related]
5. Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature.
Dimentberg E; Marceau MP; Lachance A; Bergeron-Gravel S; Saikali S; Crevier L; Bourget C; Hawkins C; Jabado N; Giannakouros P; Renzi S; Larouche V
J Pediatr Hematol Oncol; 2024 May; 46(4):211-215. PubMed ID: 38573000
[TBL] [Abstract][Full Text] [Related]
6. Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare disease.
Papangelopoulou D; Bison B; Behrens L; Bailey S; Ansari M; Ehlert K; Martinez OC; Kramm CM; Morales La Madrid A; von Bueren AO
Childs Nerv Syst; 2024 Apr; 40(4):1053-1064. PubMed ID: 38376530
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
[TBL] [Abstract][Full Text] [Related]
8. Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.
Vinci M; Burford A; Molinari V; Kessler K; Popov S; Clarke M; Taylor KR; Pemberton HN; Lord CJ; Gutteridge A; Forshew T; Carvalho D; Marshall LV; Qin EY; Ingram WJ; Moore AS; Ng HK; Trabelsi S; H'mida-Ben Brahim D; Entz-Werle N; Zacharoulis S; Vaidya S; Mandeville HC; Bridges LR; Martin AJ; Al-Sarraj S; Chandler C; Sunol M; Mora J; de Torres C; Cruz O; Carcaboso AM; Monje M; Mackay A; Jones C
Nat Med; 2018 Aug; 24(8):1204-1215. PubMed ID: 29967352
[TBL] [Abstract][Full Text] [Related]
9. MELK Inhibition in Diffuse Intrinsic Pontine Glioma.
Meel MH; de Gooijer MC; Guillén Navarro M; Waranecki P; Breur M; Buil LCM; Wedekind LE; Twisk JWR; Koster J; Hashizume R; Raabe EH; Montero Carcaboso A; Bugiani M; van Tellingen O; van Vuurden DG; Kaspers GJL; Hulleman E
Clin Cancer Res; 2018 Nov; 24(22):5645-5657. PubMed ID: 30061363
[No Abstract] [Full Text] [Related]
10. Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.
Mackay A; Burford A; Molinari V; Jones DTW; Izquierdo E; Brouwer-Visser J; Giangaspero F; Haberler C; Pietsch T; Jacques TS; Figarella-Branger D; Rodriguez D; Morgan PS; Raman P; Waanders AJ; Resnick AC; Massimino M; Garrè ML; Smith H; Capper D; Pfister SM; Würdinger T; Tam R; Garcia J; Thakur MD; Vassal G; Grill J; Jaspan T; Varlet P; Jones C
Cancer Cell; 2018 May; 33(5):829-842.e5. PubMed ID: 29763623
[TBL] [Abstract][Full Text] [Related]
11. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma.
Lin GL; Nagaraja S; Filbin MG; Suvà ML; Vogel H; Monje M
Acta Neuropathol Commun; 2018 Jun; 6(1):51. PubMed ID: 29954445
[TBL] [Abstract][Full Text] [Related]
12. Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG).
Bailey CP; Figueroa M; Mohiuddin S; Zaky W; Chandra J
Bioengineering (Basel); 2018 Oct; 5(4):. PubMed ID: 30340362
[TBL] [Abstract][Full Text] [Related]
13. H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers.
Fang D; Gan H; Cheng L; Lee JH; Zhou H; Sarkaria JN; Daniels DJ; Zhang Z
Elife; 2018 Jun; 7():. PubMed ID: 29932419
[TBL] [Abstract][Full Text] [Related]
14. Pediatric diffuse intrinsic pontine glioma: where do we stand?
Rashed WM; Maher E; Adel M; Saber O; Zaghloul MS
Cancer Metastasis Rev; 2019 Dec; 38(4):759-770. PubMed ID: 31802357
[TBL] [Abstract][Full Text] [Related]
15. Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets.
Aziz-Bose R; Monje M
Curr Opin Oncol; 2019 Nov; 31(6):522-530. PubMed ID: 31464759
[TBL] [Abstract][Full Text] [Related]
16. Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
El-Khouly FE; Veldhuijzen van Zanten SEM; Santa-Maria Lopez V; Hendrikse NH; Kaspers GJL; Loizos G; Sumerauer D; Nysom K; Pruunsild K; Pentikainen V; Thorarinsdottir HK; Rutkauskiene G; Calvagna V; Drogosiewicz M; Dragomir M; Deak L; Kitanovski L; von Bueren AO; Kebudi R; Slavc I; Jacobs S; Jadrijevic-Cvrlje F; Entz-Werle N; Grill J; Kattamis A; Hauser P; Pears J; Biassoni V; Massimino M; Lopez Aguilar E; Torsvik IK; Joao Gil-da-Costa M; Kumirova E; Cruz-Martinez O; Holm S; Bailey S; Hayden T; Thomale UW; Janssens GOR; Kramm CM; van Vuurden DG
J Neurooncol; 2019 Oct; 145(1):177-184. PubMed ID: 31522324
[TBL] [Abstract][Full Text] [Related]
17. CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma.
Hoeman C; Shen C; Becher OJ
Front Oncol; 2018; 8():191. PubMed ID: 29904623
[TBL] [Abstract][Full Text] [Related]
18. Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event.
Koschmann C; Farooqui Z; Kasaian K; Cao X; Zamler D; Stallard S; Venneti S; Hervey-Jumper S; Garton H; Muraszko K; Franchi L; Robertson PL; Leonard M; Opipari V; Castro MG; Lowenstein PR; Chinnaiyan A; Mody R
NPJ Precis Oncol; 2017; 1(1):32. PubMed ID: 29872713
[TBL] [Abstract][Full Text] [Related]
19. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
Chi AS; Tarapore RS; Hall MD; Shonka N; Gardner S; Umemura Y; Sumrall A; Khatib Z; Mueller S; Kline C; Zaky W; Khatua S; Weathers SP; Odia Y; Niazi TN; Daghistani D; Cherrick I; Korones D; Karajannis MA; Kong XT; Minturn J; Waanders A; Arillaga-Romany I; Batchelor T; Wen PY; Merdinger K; Schalop L; Stogniew M; Allen JE; Oster W; Mehta MP
J Neurooncol; 2019 Oct; 145(1):97-105. PubMed ID: 31456142
[TBL] [Abstract][Full Text] [Related]
20. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.
Panditharatna E; Kilburn LB; Aboian MS; Kambhampati M; Gordish-Dressman H; Magge SN; Gupta N; Myseros JS; Hwang EI; Kline C; Crawford JR; Warren KE; Cha S; Liang WS; Berens ME; Packer RJ; Resnick AC; Prados M; Mueller S; Nazarian J
Clin Cancer Res; 2018 Dec; 24(23):5850-5859. PubMed ID: 30322880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
